"Southeast BIO (SEBIO)'s mission is to foster the growth of the life sciences industry in the Southeastern United States by promoting entrepreneurship and bringing together the key stakeholders active in the development of the industry."

Final hours for Early Bird Prices!!

Register now to attend the region’s premiere life sciences and medical technology conference connecting emerging companies with potential investors and corporate partners. Celebrating its 20th anniversary, the Southeast BIO Investor & Partnering Forum returns to Atlanta on November 13-14, 2018 with a new format, new networking opportunities, and new investment prospects.

read more

Registration Open for SEBIO 2018!!

Celebrating its 20th Anniversary, the Southeast BIO Investor & Partnering Forum returns to Atlanta on November 13-14, 2018 with a new format, new networking opportunities, and new investment prospects.

read more

Precision BioSciences Inks $445M-Plus Hepatitis B Deal With Gilead

DURHAM, N.C. – Precision BioSciences, a Durham-based genome editing company, has formed a strategic collaboration potentially worth more than $445 million with globalbiopharmaceutical company Gilead Sciences, to develop new therapies aimed at curing hepatitis B infections.

read more